Advice
following an abbreviated submission:
testosterone gel (Testim) is accepted for restricted use within NHSScotland as replacement therapy for adult male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.
It is an alternative to another formulation of testosterone gel, of the same strength and cost, and is restricted to use as an alternative to testosterone gel patches for those patients requiring a transdermal delivery system. Testosterone is at least as effective as testosterone patches and costs less.
Download detailed advice27KB (PDF)
Medicine details
- Medicine name:
- testosterone gel (Testim)
- SMC ID:
- 284/06
- Indication:
- as replacement therapy for adult male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.
- Pharmaceutical company
- Ipsen Ltd
- BNF chapter
- Endocrine system
- Submission type
- Abbreviated
- Status
- Restricted
- Date advice published
- 10 July 2006